Pharmaceutical Technology via Yahoo
Cardurion closes $260m in Series B to develop cardiovascular pipeline
Both therapies are being evaluated in Phase II trials. The company also plans to use the fund to expand the number of indications being explored for the two candidates and acquire additional ...
43 minutes ago